Trends in the indication and method of liver biopsy for hepatitis B and C

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2971-2976

  Lipp, Michael J ^a   D'Souza, Lionel S ^a   Clain, David J ^a   Bodenheimer Jr , Henry C ^a   Min, Albert D ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Chronic hepatitis; Complications; Liver biopsy; Ultrasound

Indexed keywords

ARTICLE; CONTROLLED STUDY; DATA BASE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PATHOLOGY; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; RETROSPECTIVE STUDY; TREATMENT INDICATION; BIOPSY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FACTUAL DATABASE; GASTROENTEROLOGY; LIVER; UTILIZATION REVIEW;

BIOPSY; DATABASES, FACTUAL; GASTROENTEROLOGY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77957924755     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1337-8     Document Type: Article

References (21)

1. FDA Consumer, July-August 2001. Available at: http://perma nent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/ 401-hepc.html. Accessed 07 June 2010.
2. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
3. Strader DB, Wright T, Thomas DL, et al. AASLD practice guidelines-diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147-1171.
4. Lai M, Hyatt BJ, Nasser I, et al. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760-767.
5. Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-Infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008;134:1376-1384.
6. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol. 2008;14(21):3396-3402.
7. Al Knawy B, Shiffman Mitchell. Percutaneous liver biopsy in clinical practice. Liver Int. 2007;27(9):1166-1173.
8. Sheela H, Seela S, Caldwell C, et al. Liver biopsy-evolving role in the new millennium. J Clin Gastroenterol. 2005;39:603-610.
9. Muir AJ, Trotter JF. A survey of current liver biopsy practices. J Clin Gastroenterol. 2002;35(1):86-88.
10. Angtuaco TL, Lal SK, Banaad-Omiotek GD, et al. Current liver biopsy practices for suspected parenchymal liver diseases in the United States: the evolving role of radiologists. Am J Gastroenterol. 2002;97(6):1468-1471.
11. Riley TR III. How often does ultrasound marking change the liver biopsy site. Am J Gastroenterol. 1999;94:3320-3322.
12. Caturelli E, Giacobbe A, Facciorusso D, et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol. 1996;91:1318-1321.
13. The gastroenterology core curriculum, 3rd ed. Gastroenterology. 2007;132(5):2012-2018.
14. National Institutes of Health. NIH consensus statement on management of hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19(3):1-46.
15. National Institutes of Health. Management of hepatitis C. NIH Consens Statement Online. 1997;15(3):1-41.
16. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol. 2004;2:87-106.
17. Lok AS, McMahon BJ. Practice guidelines committee, AASLD. Chronic hepatitis B. Hepatology. 2001;34(6):1225-1241.
18. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45(2):507-539.
19. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6(12):1315-1341.
20. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-662.
21. Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49(3):1017-1044.